R&D
Sponsored
Beyond weight loss: How obesity trial design is evolving
For many years, body weight sat at the centre of obesity drug development.
Patients
ASCO 26: Three cancer survivors share lessons for the field
In honour of National Cancer Survivors' Day, we recount three patient testimonies and calls to action from ASCO Voices at ASCO 2026.
Oncology
ASCO 2026: Chinese firms take a front seat in oncology, with...
Dr Li Mao and Dr Giovanni Selvaggi of Betta Pharmaceuticals and Xcovery Holdings discuss their novel ALK inhibitor and the Chinese biotech landscape.
Oncology
Cancer patients don’t care where the breakthrough happened. ...
National Cancer Survivors’ Day highlighted decades of progress against cancer, but oncology faces a new challenge.
Digital
Disruptive healthtech, personalisation & investment appetite
Bringing genuinely transformative healthcare innovations from concept to commercial reality is becoming increasingly complex.
Sales & Marketing
Digital
Market Access
Editor's Picks
Editor's Picks
